ClinicalTrials.gg
CompletedNCT03375749Updated Dec 4, 2018

StandUP UBC: Reducing Workplace Sitting

An interventional study of Standing desk intervention and Waitlist control in Sedentary Lifestyle, sponsored by University of British Columbia. Completed at 1 site in Canada. Open to participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-12-04.

Sponsored by University of British Columbia · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

Research indicates that sedentary behaviours, such as prolonged sitting, have negative health consequences and increases risk for disease. Unfortunately, many office-workers spend a high proportion of their workday sitting, often in prolonged unbroken bouts. Recent interventions have provided active workstations (e.g., sit-stand desks) to reduce employee sitting. However, cost prohibits provision of these desks in work environments. There is a need for low-cost solutions to reduce sitting at work. The purpose of this study is to determine whether provision of a low-cost standing desk reduces workplace sitting, and results in improvements in work engagement and fatigue, compared to usual practice.

Read the detailed description

Study objectives: This study aims to provide a cost-effective solution to reducing sitting time during the workday, through provision of (1) low-cost cardboard standing desks ($20), and (2) simple behaviour change strategies (e.g., instruction on how to break up sitting time and information on the health consequences of doing so).

Background: Sedentary behaviour, defined as 'any waking behaviour characterised by an energy expenditure ≤1.5 metabolic equivalents while in a sitting, reclining, or lying posture', is a risk factor for poor health, independent of moderate-to-vigorous physical activity (MVPA). High levels of sedentary behaviour and excessive bouts of prolonged sitting is associated with increased risk for developing type 2 diabetes, cardiovascular disease and some cancers.

Sedentary behaviours are prevalent among Canadian adults, who often spend a large proportion of their waking hours sitting (e.g., work, commuting, watching TV), and office workers have been identified as one of the most sedentary occupational groups. Sedentary behaviour can be reduced by replacing sitting time with standing or light ambulation. In order to do so, it is vital to create an environment that makes sitting less likely and standing/moving easier. There is some evidence that introduction of sit-stand desks can reduce occupational sitting time within office environments ; however, there are cost barriers to the provision of these desks in work environments and few randomized control trials have demonstrated the long-term compliance and effectiveness of these desks on health- (e.g., weight, waist circumference, blood-derived biomarkers, musculoskeletal symptoms, fatigue) and work-related (e.g., work performance/productivity) outcomes. These are important factors that need to be considered and studied in further detail to quantify the benefit of sit-stand workstations.

Therefore, the purpose of this study is to evaluate the long-term effectiveness of a low-cost intervention aimed at reducing workplace sitting time in office workers.

Primary objectives:

  • To evaluate the effectiveness of the intervention at reducing daily occupational sitting time over 6 months.

Secondary objectives:

  • To explore whether the intervention results in improvements in work engagement and productivity, and occupational fatigue.

Methods/Design: The intervention will be delivered and evaluated over a 6-month period. This study is a two-arm randomized waitlist-controlled trial with one intervention group and one control group. After eligibility assessment, individuals will be randomly allocated to either the intervention or the control arm. The experimental group participants will receive a low-cost cardboard standing desk converter in their regular office environment and behaviour change strategies to break up sitting time, while the control group participants will not encounter any change to their regular work environments or be provided with any behaviour change strategies.

Intervention for experimental group:

Each participant allocated to the experimental group will receive a low-cost, cardboard, fixed-height standing desk converter (https://oristand.co/) that will be placed in their regular office environment, along with their usual sitting desk. The participants will be instructed on how to use the fixed-height standing desk converter (herein referred to as standing desk) as a way to break up sitting time every 30 minutes. In addition, each participant will be provided with information about the health benefits of breaking up sitting time.

Waitlist Control group:

Control group participants will not encounter any changes to their regular office environment. They will be provided with the standing desk and behaviour change strategies 6-months post-intervention.

02

Conditions studied

  • Sedentary Lifestyle

Browse trials for

Keywords

  • sitting
03

In context

Sedentary Behavior

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's enrollment of 48 is below the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,339 studies on the registry; 259 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (1) individuals who are desk-based (>75% of seated working hours),
  • (2) work at least three days a week using the same desk,
  • (3) aged 18-64 years, and
  • (4) have the capability of standing.

Exclusion criteria

Exclusion Criteria:

  • (1) individuals who are not predominantly desk-based (\<75% seated working hours),
  • (2) work less than three days a week in the same office, or will not be working for the full duration of the study (i.e., retirement, term-time only, maternity/extended leave),
  • (3) self-report having severe musculoskeletal conditions which restrict them from standing,
  • (4) already use a standing desk.
  • (5) unable to read or understand English or provide full .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    Standing Desk Intervention

    Each participant allocated to the experimental group will receive a low-cost, cardboard, fixed-height standing desk converter (https://oristand.co/) that will be placed in their regular office environment, along with their usual sitting desk. The participants will be instructed on how to use the fixed-height standing desk converter (herein referred to as standing desk) as a way to break up sitting time every 30 minutes. In addition, each participant will be provided with information about the health benefits of breaking up sitting time.

    Behavioral: Standing desk intervention

  • Other
    Waitlist Control

    Control group participants will not encounter any changes to their regular office environment. They will be provided with the standing desk and behaviour change strategies 6-months post-intervention.

    Behavioral: Waitlist control

Interventions

  • BehavioralStanding desk intervention

    Standing desk converter

  • BehavioralWaitlist control

    Control

06

What researchers measure

Primary outcomes

  1. Reduction in sitting time

    Daily minutes sitting time measured with an activPAL3 micro activity monitor

    Time frame: Baseline, 3 months and 6 months

  2. Reduced number of prolonged sitting bouts (>30 min)

    Number of daily bouts of sitting (\>30 mins) measured with an activPAL3 micro activity monitor

    Time frame: Baseline, 3 months and 6 months

Secondary outcomes

  1. Work engagement

    Utrecht Work Engagement Scale (UWES). Work engagement will be measured using the Utrecht Work Engagement Scale (UWES), a 7-point likert scale ("never" \[0\]to "always" \[6\]). There are three sub-scales: vigour, dedication, and absorption. The mean scale score of the three UWES subscales is computed by adding the 3 scores on each particular scale and dividing the sum by the number of items of the subscale involved. A similar procedure is followed for the total score. Hence, the UWES yields three subscale scores and/or a total score that range between 0 and 6. Higher values reflect better outcomes.

    Time frame: Baseline, 3 months and 6 months

  2. Occupational fatigue

    Need for Recovery (NFR) scale. Occupational fatigue will be measured using the 11-item Need for Recovery (NFR) scale. Indicators of fatigue assessed on the NFR scale include a lack of concentration and reduced motivation for activities at the end of the day. Participants are given dichotomous response options (yes/no) to answer whether or not they experience each indicator. The total number of indicators present for each individual is converted into a scale score which ranges from 0 to 100, where higher scores show a greater need for recovery and thereby greater short-term work-related fatigue.

    Time frame: Baseline, 3 months and 6 months

07

Study locations

1 site
  • University of British Columbia
    Vancouver, British Columbia V6T 1Z4, Canada
08

References and documents

Publications

  • Tremblay MS, Aubert S, Barnes JD, Saunders TJ, Carson V, Latimer-Cheung AE, Chastin SFM, Altenburg TM, Chinapaw MJM; SBRN Terminology Consensus Project Participants. Sedentary Behavior Research Network (SBRN) - Terminology Consensus Project process and outcome. Int J Behav Nutr Phys Act. 2017 Jun 10;14(1):75. doi: 10.1186/s12966-017-0525-8. PubMed 28599680 ↗
  • Shrestha N, Kukkonen-Harjula KT, Verbeek JH, Ijaz S, Hermans V, Bhaumik S. Workplace interventions for reducing sitting at work. Cochrane Database Syst Rev. 2016 Mar 17;3(3):CD010912. doi: 10.1002/14651858.CD010912.pub3. PubMed 26984326 ↗
  • Neuhaus M, Eakin EG, Straker L, Owen N, Dunstan DW, Reid N, Healy GN. Reducing occupational sedentary time: a systematic review and meta-analysis of evidence on activity-permissive workstations. Obes Rev. 2014 Oct;15(10):822-38. doi: 10.1111/obr.12201. Epub 2014 Jul 11. PubMed 25040784 ↗
  • Weatherson K, Yun L, Wunderlich K, Puterman E, Faulkner G. Application of an Ecological Momentary Assessment Protocol in a Workplace Intervention: Assessing Compliance, Criterion Validity, and Reactivity. J Phys Act Health. 2019 Nov 1;16(11):985-992. doi: 10.1123/jpah.2019-0152. Epub 2019 Sep 20. PubMed 31541068 ↗
  • Weatherson KA, Wunderlich KB, Faulkner GE. Impact of a low-cost standing desk on reducing workplace sitting (StandUP UBC): A randomised controlled trial. Appl Ergon. 2020 Jan;82:102951. doi: 10.1016/j.apergo.2019.102951. Epub 2019 Sep 14. PubMed 31526916 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2018 to primary completion in Sep 2018, 8 months.

Of 733 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's 8 months is below that.

Counting every sponsor, half of 741 studies reached it within 14 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 12, 2017
First posted
Dec 18, 2017
StartActual
Jan 15, 2018
Primary completionActual
Sep 26, 2018
CompletionActual
Sep 26, 2018
Last update
Dec 4, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 4, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03375749
Responsible party
Guy Faulkner (Professor, University of British Columbia) — Principal investigator
First posted
Dec 18, 2017
Start date
Jan 15, 2018
Primary completion
Sep 26, 2018
Completion
Sep 26, 2018
Last update
Dec 4, 2018

Study contacts

Guy Faulkner, PhD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion